Allergan (Australia)

Alternate names: Allergan Australia, Allergan Australia Pty Ltd

ROR: 022gczz96

OpenAlex ID: I4405279828

Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study

2013 · Peter Callan, Michael Halstead, et al. · Clinical Cosmetic and Investigational Dermatology · 127

PDF

An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study

2013 · Nicholas R. Fuller, Suzanne Pearson, et al. · Obesity · 110

PDF

Induction of δ-Opioid Receptor Function in the Midbrain after Chronic Morphine Treatment

2005 · Stephen P. Hack, Elena E. Bagley, et al. · Journal of Neuroscience · 84

PDF

A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds: a multicenter, prospective, randomized, controlled, single-blind, within-subject study

2011 · Greg Goodman, Bekhor, et al. · Clinical Cosmetic and Investigational Dermatology · 41

PDF

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study

2019 · Catherine Stark, Richard Stark, et al. · The Journal of Headache and Pain · 33

PDF

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study

2023 · Paul Mitchell, Jennifer Arnold, et al. · BMJ Open Ophthalmology · 21

PDF

Mapping of Incontinence Quality of Life (I-QOL) scores to Assessment of Quality of Life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder

2014 · Gang Chen, Jonathan T Tan, et al. · Health and Quality of Life Outcomes · 19

PDF

Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study

2021 · Samantha Fraser-Bell, Hyong Kwon Kang, et al. · British Journal of Ophthalmology · 18

PDF

Botulinum Toxin Injection into Riolan’s Muscle: Somatosensory ‘Trick’

2007 · Ken Inoue, John D. Rogers · European Neurology · 17

Barriers To Intravitreal Injection Therapy Adherence In Dme Patients In Australia

2016 · R Schnabel, J Tan, et al. · Value in Health · 8

Effectiveness of social egg freezing: protocol for systematic review and meta-analyses

2019 · Alex Wang, Fekede Asefa Kumsa, et al. · BMJ Open · 4

PDF

OnabotulinumtoxinA treatment of moderate to severe glabellar lines in Chinese subjects after laser therapy: A prospective, open-label, noncomparative study

2018 · Yan Wu, Zhong Lu, et al. · Journal of Cosmetic and Laser Therapy · 2

PDF

Efficacy and Safety of OnabotulinumtoxinA in a Long-Term, Open-Label Study for the Prophylaxis of Headaches in Adult Chronic Migraine Patients: An Interim Analysis of the COMPEL Study (P1.306)

2015 · Andrew Blumenfeld, Richard Stark, et al. · Neurology · 2

Poster 308: The Effect of Botulinum Toxin Type A on Walking Speed in Poststroke Patients: A Subgroup Analysis of Patients in a 2-Part, 32-Week, Multicenter Study

2007 · Fiona Napier-Flood, John Olver, et al. · Archives of Physical Medicine and Rehabilitation · 1

Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion

2022 · Paul Mitchell, Prabhjot Juneja, et al. · Clinical and Experimental Ophthalmology

PDF

The real-world efficacy of botulinum toxin type a (botox®) for the prophylaxis of headaches in adult patients with chronic migraine in australian clinical practice: a retrospective chart review

2017 · Catherine Stark, Richard Stark, et al. · Journal of Neurology Neurosurgery & Psychiatry

Real-World Outcomes and Resource Utilisation Following Onabotulinumtoxina Treatment For Severe Lower Limb Focal Spasticity in Adults – Database Analysis at An Australian Hypertonicity Clinic

2016 · MJ Frost, C Cave, et al. · Value in Health

PDF

PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

2012 · J.T. Tan, M. Frost, et al. · Value in Health

PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic Migraine

2012 · V. Gamble, N. Vogel, et al. · Value in Health

Poster 4: Effect of Botulinum Toxin Type A on Walking Speed in Poststroke Patients: A Subgroup Analysis of Patients in a 2-Part, 32-Week, Multicenter Study

2007 · Fiona Napier-Flood, John Olver, et al. · Archives of Physical Medicine and Rehabilitation

Works count: 20

Citation count: 834